These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3480764)

  • 1. Doxorubicin and epirubicin iron-induced generation of free radicals in vitro. A comparative study.
    Grankvist K; Henriksson R
    Biosci Rep; 1987 Aug; 7(8):653-8. PubMed ID: 3480764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of demethoxydaunorubicin with other anthracyclines on generation of oxygen radicals and clonogenic survival of fibroblasts.
    Grankvist K; Stendahl U; Henriksson R
    Pharmacol Toxicol; 1989 Jul; 65(1):40-4. PubMed ID: 2780507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of iron chelators on epirubicin-induced fibroblast toxicity.
    Henriksson R; Grankvist K
    Cancer Lett; 1988 Dec; 43(3):179-83. PubMed ID: 3144433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of doxorubicin, 4'-epirubicin, and antioxidant enzymes on the contractility of isolated cardiomyocytes.
    Chan EM; Thomas MJ; Bandy B; Tibbits GF
    Can J Physiol Pharmacol; 1996 Aug; 74(8):904-10. PubMed ID: 8960379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of idarubicin and epirubicin on in vitro polymorphonuclear function: diminished superoxide radical formation compared to their parent compounds daunorubicin and doxorubicin.
    Cairo MS; Toy C; Sender L; van de Ven C
    J Leukoc Biol; 1990 Mar; 47(3):224-33. PubMed ID: 2155275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin reduces the iron(III) complexes of the hydrolysis products of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and produces hydroxyl radicals.
    Malisza KL; Hasinoff BB
    Arch Biochem Biophys; 1995 Feb; 316(2):680-8. PubMed ID: 7864623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of adriamycin toxicity by iron chelates is not a free radical mechanism.
    Gelvan D
    Biol Trace Elem Res; 1997 Mar; 56(3):295-309. PubMed ID: 9197926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse.
    Toldo S; Goehe RW; Lotrionte M; Mezzaroma E; Sumner ET; Biondi-Zoccai GG; Seropian IM; Van Tassell BW; Loperfido F; Palazzoni G; Voelkel NF; Abbate A; Gewirtz DA
    PLoS One; 2013; 8(3):e58421. PubMed ID: 23516478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of daunosamine and hydroxyacetyl side chain in reaction with iron and lipid peroxidation by anthracyclines.
    Gianni L; Viganò L; Lanzi C; Niggeler M; Malatesta V
    J Natl Cancer Inst; 1988 Sep; 80(14):1104-11. PubMed ID: 3137359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer.
    Danesi R; Conte PF; Del Tacca M
    Clin Pharmacokinet; 1999 Sep; 37(3):195-211. PubMed ID: 10511918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. II. Amrubicin shows metabolic advantages over doxorubicin and epirubicin.
    Salvatorelli E; Menna P; Gonzalez Paz O; Surapaneni S; Aukerman SL; Chello M; Covino E; Sung V; Minotti G
    J Pharmacol Exp Ther; 2012 May; 341(2):474-83. PubMed ID: 22338034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model.
    Alderton PM; Gross J; Green MD
    Cancer Res; 1992 Jan; 52(1):194-201. PubMed ID: 1727379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human heart cytosolic reductases and anthracycline cardiotoxicity.
    Mordente A; Meucci E; Martorana GE; Giardina B; Minotti G
    IUBMB Life; 2001 Jul; 52(1-2):83-8. PubMed ID: 11795600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of anthracycline antibiotics with human neutrophils: superoxide production, free radical formation and intracellular penetration.
    Schinetti ML; Rossini D; Bertelli A
    J Cancer Res Clin Oncol; 1987; 113(1):15-9. PubMed ID: 3029137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of oxygen free radicals and cardiac sarcoplasmic reticulum: proposed role in the pathogenesis of endotoxin shock.
    Manson NH; Hess ML
    Circ Shock; 1983; 10(3):205-13. PubMed ID: 6851003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective taxane stimulation of epirubicinol formation in the human heart: insight into the cardiac tolerability of epirubicin-taxane chemotherapies.
    Salvatorelli E; Menna P; Gianni L; Minotti G
    J Pharmacol Exp Ther; 2007 Feb; 320(2):790-800. PubMed ID: 17135345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin.
    Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J
    Cancer Chemother Pharmacol; 1995; 35(3):257-61. PubMed ID: 7805186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
    Kaiserová H; den Hartog GJ; Simůnek T; Schröterová L; Kvasnicková E; Bast A
    Br J Pharmacol; 2006 Dec; 149(7):920-30. PubMed ID: 17031387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological changes and catalase activity in the hearts of CD 1 mice following acute starvation or single doses of doxorubicin, epirubicin or mitoxantrone.
    Crescimanno M; Flandina C; Rausa L; Sanguedolce R; D'Alessandro N
    Chemioterapia; 1988 Feb; 7(1):53-9. PubMed ID: 3163942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability and iron coordination in DNA adducts of Anthracycline based anti-cancer drugs.
    Eizaguirre A; Yáñez M; Eriksson LA
    Phys Chem Chem Phys; 2012 Sep; 14(36):12505-14. PubMed ID: 22699973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.